← Back to Search

Usability Study for HIV (ANCHORS Trial)

N/A
Waitlist Available
Led By Robert Leeman, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up retrospective self-report from past 1-3 months on web survey
Awards & highlights

ANCHORS Trial Summary

This trial will test a mobile intervention to reduce alcohol and HIV risk in young adult MSM.

ANCHORS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~retrospective self-report from past 1-3 months on web survey
This trial's timeline: 3 weeks for screening, Varies for treatment, and retrospective self-report from past 1-3 months on web survey for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
High-risk sexual behavior
Quantity of alcohol consumption
Study participant opinions on intervention content

ANCHORS Trial Design

3Treatment groups
Active Control
Group I: Usability StudyActive Control2 Interventions
10 young adult MSM will test the mobile intervention in development for 30 days in order to establish usability, acceptability and correct any functionality issues.
Group II: Focus GroupActive Control2 Interventions
30 young MSM who drink regularly to inform the content of the alcohol and HIV preventive intervention tested in the UH3 phase and ensure the intervention is culturally appropriate for MSM.
Group III: Survey groupActive Control1 Intervention
Collect alcohol and sexual activity data via web survey from 683 young MSM to yield normative data for the alcohol and HIV preventive intervention in a follow-up study

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
801 Previous Clinical Trials
1,365,373 Total Patients Enrolled
University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,654 Total Patients Enrolled
Robert Leeman, PhDPrincipal InvestigatorUniversity of Florida
3 Previous Clinical Trials
122 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people with the relevant medical conditions currently able to participate in this trial?

"The clinical trial in question is not looking for enrolment at this time. This is according to the information present on clinicaltrials.gov. The page was last updated on June 10th, 2022 and the trial was first posted on December 1st, 2017. There are, however, 110 other trials that are actively recruiting patients."

Answered by AI

Are there any restrictions on who can be a part of this research project?

"Eligibility requirements for this clinical trial include being between 18-35 years old and being infected with human immunodeficiency virus type 1 (hiv-1). Around 24 individuals are needed for the study."

Answered by AI

Is there an age limit for potential participants in this clinical trial?

"This particular clinical trial only allows for patients aged 18 to 35 to enroll. However, if the patient does not meet this age criterion, there are 18 other clinical trials that they could potentially enroll in. For patients over the age of 65, there are 87 other clinical trials that they could participate in."

Answered by AI
~3 spots leftby Apr 2025